Board Change
2008年7月1日 - 3:01PM
RNSを含む英国規制内ニュース (英語)
RNS Number : 9619X
Northwest Biotherapeutics Inc
01 July 2008
For Immediate Release 1 July 2008
Northwest Biotherapeutics
("NWBT" or "the Company")
Board Change
Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announces the resignation, effective July 1, 2008, of R. Steve
Harris as a non-executive member of the Board of Directors of the Company. The Company expects to announce a replacement shortly.
Linda F. Powers, Chairperson of the Company's Board of Directors, commented: "We would like to thank Steve for his contributions to the
Company."
Steve Harris added: "I wish Northwest Biotherapeutics every success in the continuing development of DCVax�-Brain and other applications
of the Company's very promising technology."
For further information, please contact:
Northwest Biotherapeutics
Anthony P. Deasey, Chief Financial Officer +1 240-497-9024
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane +44 (0)20 7466 5000
Johnson / Catherine Breen
Collins Stewart
Adam Cowen/Tim Mickley +44 (0)20 7523 8230
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABCGDLIXXGGIG
Northw.Bio Regs (LSE:NWBS)
過去 株価チャート
から 5 2024 まで 6 2024
Northw.Bio Regs (LSE:NWBS)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Northw.Bio Regs (ロンドン証券取引所): 0 recent articles
その他のNorthwest Bio.ニュース記事